Breast Cancer Network Australia
Policy & Advocacy Program
for reconstruction surgery and sets out clear recommendations to address these for government. In 2023, to support our focus on improving equity of access to optimal care, our Making Metastatic Breast Cancer Count issues paper highlighted the lack of data that is hindering support for those with metastatic breast cancer. As we work toward the final year of this strategy, we will continue our focus on metastatic breast cancer, ensuring those living with this disease are heard. We will also continue to advocate for greater investment in services providing specialised mental health support and other supportive care needs for those living with and beyond breast cancer.
BCNA's Policy & Advocacy Strategy 2021–2024 In 2021, BCNA developed its first multi-year policy and advocacy strategy following extensive consultation with our network to identify key issues for consumers. This strategy is guiding our policy and advocacy efforts through to 2024. Key outcomes from our focus on the financial impacts of breast cancer in 2022 have been the listing of Trodelvy on the Pharmaceutical Benefits Scheme, an important drug that extends quality of life for people living with metastatic breast cancer, and the release of our Breast Reconstruction in Australia 2021 Report that revealed unacceptable out of pocket costs
Mr Douglas Macmillan, Sam Mills, Dr Jodi Steel, Dr Sanjay Warrier and Kirsten Pilatti at the 2022 Australasian International Breast Congress. Brisbane, Queensland
12
Made with FlippingBook - professional solution for displaying marketing and sales documents online